169 related articles for article (PubMed ID: 23206584)
41. High pretreatment serum concentration of basic fibroblast growth factor is a predictor of poor prognosis in small cell lung cancer.
Ruotsalainen T; Joensuu H; Mattson K; Salven P
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1492-5. PubMed ID: 12433733
[TBL] [Abstract][Full Text] [Related]
42. [Correlation of preoperative serum vascular endothelial growth factor level with CA125 level in patients with epithelial ovarian cancer and its prognostic value].
Tan XJ; Lang JH; Shen K; Wang L; Wu M; Xu XY
Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):9-12. PubMed ID: 18366924
[TBL] [Abstract][Full Text] [Related]
43. High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma.
Neben K; Moehler T; Egerer G; Kraemer A; Hillengass J; Benner A; Ho AD; Goldschmidt H
Clin Cancer Res; 2001 Sep; 7(9):2675-81. PubMed ID: 11555579
[TBL] [Abstract][Full Text] [Related]
44. [Clinical significance of vascular endothelial growth factor in sera of patients with gynaecological malignant tumors].
Peng XP; Li JD; Li MD; Ye XM; Yan WC
Ai Zheng; 2002 Feb; 21(2):181-5. PubMed ID: 12479072
[TBL] [Abstract][Full Text] [Related]
45. Soluble syndecan-1 and serum basic fibroblast growth factor are new prognostic factors in lung cancer.
Joensuu H; Anttonen A; Eriksson M; Mäkitaro R; Alfthan H; Kinnula V; Leppä S
Cancer Res; 2002 Sep; 62(18):5210-7. PubMed ID: 12234986
[TBL] [Abstract][Full Text] [Related]
46. The prognostic significance of age in surgically staged patients with Type II endometrial carcinoma.
Vance S; Yechieli R; Cogan C; Hanna R; Munkarah A; Elshaikh MA
Gynecol Oncol; 2012 Jul; 126(1):16-9. PubMed ID: 22507535
[TBL] [Abstract][Full Text] [Related]
47. The associations between serum VEGF, bFGF and endoglin levels with microvessel density and expression of proangiogenic factors in malignant and benign ovarian tumors.
Szubert S; Moszynski R; Michalak S; Nowicki M; Sajdak S; Szpurek D
Microvasc Res; 2016 Sep; 107():91-6. PubMed ID: 27312585
[TBL] [Abstract][Full Text] [Related]
48. Angiogenic protein expression in advanced epithelial ovarian cancer.
Barton DP; Cai A; Wendt K; Young M; Gamero A; De Cesare S
Clin Cancer Res; 1997 Sep; 3(9):1579-86. PubMed ID: 9815846
[TBL] [Abstract][Full Text] [Related]
49. [Evaluation of the role of serum vascular endothelial growth factor and urinary basic fibroblast growth factor in differential diagnosis of vascular anomalies].
Zhang L; Chen Q; Li D; Li XW; Wang HG; Li GZ
Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(16):1092-5. PubMed ID: 21609589
[TBL] [Abstract][Full Text] [Related]
50. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients.
Salgado R; Vermeulen PB; Benoy I; Weytjens R; Huget P; Van Marck E; Dirix LY
Br J Cancer; 1999 May; 80(5-6):892-7. PubMed ID: 10360671
[TBL] [Abstract][Full Text] [Related]
51. Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood.
Di Raimondo F; Azzaro MP; Palumbo G; Bagnato S; Giustolisi G; Floridia P; Sortino G; Giustolisi R
Haematologica; 2000 Aug; 85(8):800-5. PubMed ID: 10942925
[TBL] [Abstract][Full Text] [Related]
52. Prognostic value of proangiogenic cytokines in children with lymphomas.
Mizia-Malarz A; Sobol G; Janowska J; Wos H; Zahorska-Markiewicz B
Pediatr Blood Cancer; 2009 Dec; 53(7):1195-9. PubMed ID: 19621434
[TBL] [Abstract][Full Text] [Related]
53. Preoperative serum YKL-40 is a marker for detection and prognosis of endometrial cancer.
Diefenbach CS; Shah Z; Iasonos A; Barakat RR; Levine DA; Aghajanian C; Sabbatini P; Hensley ML; Konner J; Tew W; Spriggs D; Fleisher M; Thaler H; Dupont J
Gynecol Oncol; 2007 Feb; 104(2):435-42. PubMed ID: 17023034
[TBL] [Abstract][Full Text] [Related]
54. [The relationship between the changes of proangiogenic factors serum concentrations and progression of pancreatic carcinoma patients].
Yan CQ; Zhao YP; Dai MH; Song YM; Wu YD
Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):496-8. PubMed ID: 17686314
[TBL] [Abstract][Full Text] [Related]
55. Expression of Efp, VEGF and bFGF in normal, hyperplastic and malignant endometrial tissue.
Dai H; Zhao S; Xu L; Chen A; Dai S
Oncol Rep; 2010 Mar; 23(3):795-9. PubMed ID: 20127022
[TBL] [Abstract][Full Text] [Related]
56. Serum levels of VEGF and bFGF in hypoxic patients with exacerbated COPD.
Pavlisa G; Pavlisa G; Kusec V; Kolonic SO; Markovic AS; Jaksic B
Eur Cytokine Netw; 2010 Jun; 21(2):92-8. PubMed ID: 20504760
[TBL] [Abstract][Full Text] [Related]
57. Basic fibroblast growth factor shows prognostic impact on survival in operable non-small cell lung cancer patients.
Hu MM; Hu Y; Gao GK; Han Y; Shi GL; Li BL
Thorac Cancer; 2015 Jul; 6(4):450-7. PubMed ID: 26273400
[TBL] [Abstract][Full Text] [Related]
58. A phase II trial of thalidomide in patients with refractory endometrial cancer and correlation with angiogenesis biomarkers: a Gynecologic Oncology Group study.
McMeekin DS; Sill MW; Benbrook D; Darcy KM; Stearns-Kurosawa DJ; Eaton L; Yamada SD;
Gynecol Oncol; 2007 May; 105(2):508-16. PubMed ID: 17306350
[TBL] [Abstract][Full Text] [Related]
59. Prognostic relevance of serum levels of the angiogenic peptide bFGF in advanced carcinoma of the head and neck treated by primary radiochemotherapy.
Dietz A; Rudat V; Conradt C; Weidauer H; Ho A; Moehler T
Head Neck; 2000 Oct; 22(7):666-73. PubMed ID: 11002321
[TBL] [Abstract][Full Text] [Related]
60. Visfatin, a potential biomarker and prognostic factor for endometrial cancer.
Tian W; Zhu Y; Wang Y; Teng F; Zhang H; Liu G; Ma X; Sun D; Rohan T; Xue F
Gynecol Oncol; 2013 Jun; 129(3):505-12. PubMed ID: 23438672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]